Heparin free coating on PLA membranes for enhanced hemocompatibility via iCVD
Source abstract
Abstract
Abstract In the present work, we report one-step immobilization of nano-heparin coating on PLA membranes via initiated chemical vapor deposition (iCVD) for enhanced hemocompatibility. The nano-coating introduced onto the membrane surface via the crosslinking of P(MAA-EGDA) was confirmed by the FTIR, SEM and weight measurement respectively. The negative carboxyl groups could form the hydration interaction with the protein and platelets and electrostatic interaction with amide groups of thrombin by the mediation of antithrombin, which is similar but different with heparin. The P(MAA-EGDA) coated membranes showed suppressed platelet adhesion and prolonged clotting time (APTTs increased to 59 s, PTs increased to 20.4 s, TTs increased to 17.5 s, and the FIBs declined by 30 mg/dL). Moreover, the complement activation tests demonstrated the formation of C3a and C5a was inhibited. All results demonstrated that the nano-coating of P(MAA-EGDA) via iCVD significantly enhanced the hemocompatibility of PLA membranes, which is also applicable for various membranes.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Polymer Surface Interaction Studies · Electrospun Nanofibers in Biomedical Applications · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (42)
Show source-provided references
1. Essentials of anticoagulation in hemodialysis10.1111/j.1542-4758.2007.00166.x ↗
2. A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease10.1111/j.1523-1755.2004.66022.x ↗
3. Review anticoagulation for haemodialysis10.1111/j.1440-1797.2010.01298.x ↗
4. Role of contact system activation in hemodialyzer-induced thrombogenicity10.1046/j.1523-1755.2001.00009.x ↗
5. Hemodialysis without anticoagulant: hemostasis parameters, fibrinogen kinetic, and dialysis efficiency10.1093/ndt/12.1.106 ↗
6. Risk factors of system clotting in heparin-free haemodialysis10.1093/ndt/5.9.802 ↗
7. Platelet activation in clinical haemodialysis: LMWH as a major contributor to bio-incompatibility?10.1093/ndt/gfn137 ↗
8. Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysis10.1053/j.ajkd.2012.03.017 ↗
9. Development of vitamin E-modified polysulfone membrane dialyzers10.1007/s10047-005-0318-8 ↗
10. Biocompatibility of heparin-grafted hemodialysis membranes: impact on monocyte chemoattractant protein-1 circulating level and oxidative status10.1111/j.1542-4758.2010.00494.x ↗
11. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane10.1093/ndt/gfg272 ↗
12. The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane10.1093/ndt/gfm888 ↗
13. Blood compatibility comparison for polysulfone membranes modified by grafting block and random zwitterionic copolymers via surface-initiated ATRP10.1016/j.jcis.2014.06.044 ↗
14. Polypropylene modified with 2-hydroxyethyl acrylate-g-2-methacryloyloxyethyl phosphorycholine and its hemocompatibility10.1016/j.apsusc.2010.05.028 ↗
15. APTES assisted surface heparinization of polylactide porous membranes for improved hemocompatibility10.1039/C6RA04525A ↗
16. Route to hemocompatible polyethersulfone membranes via surface aminolysis and heparinization10.1016/j.jcis.2014.02.005 ↗
17. Progress in heparin and heparin-like/mimicking polymer-functionalized biomedical membranes10.1039/C4TB01390E ↗
18. Surface modification with dopamine and heparin/poly-l-lysine nanoparticles provides a favorable release behavior for the healing of vascular stent lesions10.1021/am5015309 ↗
19. Evaluation of blood compatibility of plasma deposited heparin-like films and SF6 plasma treated surfaces10.1590/S1516-14392010000100019 ↗
20. Anticoagulant mechanism of sulfonated polyisoprenes10.1016/S0142-9612(01)00258-7 ↗
21. Heparin mimetic peptide nanofibers promote angiogenesis10.1021/bm200957s ↗
22. Functional graphene nanomaterials based architectures: biointeractions, fabrications, and emerging biological applications10.1021/acs.chemrev.6b00520 ↗
23. Heparin-like properties of sulfated alginates with defined sequences and sulfation degrees10.1021/bm500602w ↗
24. Dendritic polyglycerol sulfates as multivalent inhibitors of inflammation10.1073/pnas.1003103107 ↗
25. Modification of polyethersulfone hemodialysis membrane by blending citric acid grafted polyurethane and its anticoagulant activity10.1016/j.memsci.2012.03.015 ↗
26. Improved blood compatibility of polyethersulfone membrane with a hydrophilic and anionic surface10.1016/j.colsurfb.2012.05.004 ↗
27. Heparin-like macromolecules for the modification of anticoagulant biomaterials10.1002/mabi.201100249 ↗
28. Heparin-like surface modification of polyethersulfone membrane and its biocompatibility10.1016/j.jcis.2012.07.076 ↗
29. Chemical vapor deposition of conformal functional, and responsive polymer films10.1002/adma.200902765 ↗
30. 25th anniversary article: CVD polymers: a new paradigm for surface modification and device fabrication10.1002/adma.201301878 ↗
31. Design of conformal, substrate-independent surface modification for controlled protein adsorption by chemical vapor deposition (CVD)10.1039/C1SM06334K ↗
32. Vapor-based grafting of crosslinked poly(N-vinyl pyrrolidone) coatings with tuned hydrophilicity and anti-biofouling properties10.1039/C6TB00076B ↗
33. Controllable transition from finger-like pores to inter-connected pores of PLLA membranes10.1016/j.memsci.2015.01.004 ↗
34. Heparin-mimicking polyethersulfone membranes–hemocompatibility, cytocompatibility, antifouling and antibacterial properties10.1016/j.memsci.2015.09.054 ↗
35. Preparation, characterization and performance studies of polysulfone membranes using PVP as an additive10.1016/j.memsci.2008.02.027 ↗
36. A novel natural hirudin facilitated anti-clotting polylactide membrane via hydrogen bonding interaction10.1016/j.memsci.2016.10.027 ↗
37. Biologically inspired membrane design with a heparin-like interface: prolonged blood coagulation, inhibited complement activation, and bio-artificial liver related cell proliferation10.1039/C3BM60165J ↗
38. High efficient protocol for the modification of polyethersulfone membranes with anticoagulant and antifouling properties via in situ cross-linked copolymerization10.1016/j.memsci.2014.06.006 ↗
39. Heparin-like surface modification of polyethersulfone membrane and its biocompatibility10.1016/j.jcis.2012.07.076 ↗
40. Self-assembled 3D biocompatible and bioactive layer at the macro-interface via graphene-based supermolecules10.1039/c4py00136b ↗
41. Novel antifouling surface with improved hemocompatibility by immobilization of polyzwitterions onto silicon via click chemistry10.1016/j.apsusc.2015.12.081 ↗
42. Mechanism of the anticoagulant action of heparin10.1007/BF00421226 ↗